Eflornithine API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Eflornithine API

Eflornithine is a synthetic fluoroamino acid and an irreversible inhibitor of the enzyme ornithine decarboxylase (ODC). It is also known as α-difluoromethylornithine (DFMO) and has the chemical name 2,5-diamino-2-(difluoromethyl)pentanoic acid. Its molecular formula is C6H12F2N2O2 and its molecular weight is approximately 182.17 g/mol.

Eflornithine API Manufacturer and Supplier

Eflornithine API is a pharmaceutical active ingredient used in different therapeutic applications. Its pharmacological activity is primarily associated with inhibition of ornithine decarboxylase, an enzyme involved in polyamine biosynthesis.

Eflornithine is associated with the treatment of human African trypanosomiasis and has also been used in topical formulations for unwanted facial hair growth. More recently, oral eflornithine was approved in the United States as maintenance therapy for patients with high-risk neuroblastoma who have responded to prior treatment.

Chemical Properties of Eflornithine

Eflornithine is a fluoro-substituted amino acid structurally related to ornithine. The compound contains two fluorine atoms and two amino groups and is classified as a fluoroamino acid.

Chemical Name: 2,5-Diamino-2-(difluoromethyl)pentanoic acid
Molecular Formula: C6H12F2N2O2
Molecular Weight: 182.17 g/mol
CAS Number: 70052-12-9
Synonyms: Eflornithine, DFMO, α-Difluoromethylornithine

Mechanism of Action

Eflornithine acts as an irreversible ornithine decarboxylase inhibitor. Ornithine decarboxylase participates in the biosynthesis of polyamines, which are important for cellular growth and proliferation. Inhibition of this enzyme reduces polyamine production and contributes to the pharmacological activity of eflornithine.

Pharmaceutical Applications

Eflornithine has been used as an active pharmaceutical ingredient in formulations associated with:

  • Human African trypanosomiasis
  • Topical treatment of unwanted facial hair growth
  • Maintenance therapy for high-risk neuroblastoma following response to prior therapy

The particular application depends on the pharmaceutical formulation, regulatory approval and intended market.

Eflornithine API Quality

Eflornithine API should be manufactured and tested according to the applicable approved product specification and relevant pharmaceutical quality requirements. Typical quality evaluation may include identity, assay, related substances, water content, residue on ignition and other applicable physicochemical and analytical parameters.

Note: Numerical acceptance criteria should be taken from the manufacturer's approved specification or Certificate of Analysis rather than using generic values.

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Heavy Metals NMT 20 ppm
Individual Impurity ≤ 0.5%
Total Impurities NMT 2.0%
Water Content NMT 1.0%
Melting Point 150°C – 154°C
Get Bulk Quote via WhatsApp